Anti-angiogenic strategy aims at inhibiting tumor angiogenesis via blocking pro-angiogenic pathways (e.g. vascular endothelial growth factor (VEGF) pathway and angiopoietin 2(Ang 2) pathway) [5]. This evidence concerns the gene ANGPT2 and neoplasm.